Sangamo Therapeutics (SGMO) Misses Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -19.8%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -19.8%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.34), $0.08 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.04 million versus the consensus estimate of $8.11 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- The Lovesac Company (LOVE) Tops Q1 EPS by 29c
- BIG3 Basketball to go public via Graf Global merger at $290 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
